The FGFR3-TACC3 fusion protein has been identified with differing exonic breakpoints within TACC3 in numerous cancers including glioblastoma, bladder cancer, lung adenocarcinoma, and head and neck squamous cell carcinoma [1]. This evidence concerns the gene FGFR3 and head and neck squamous cell carcinoma.